Title21 Health Solutions’ Technology Supporting Regenerative Medicine Highlighted at Pleasanton’s Beyond the Cloud 3.0 Awards Luncheon

Pleasanton Beyond the Cloud

PRESS RELEASE | Pleasanton, CA – Title21 Health Solutions, an innovative provider of flexible and integrated technology for health science organizations, was honored at Beyond the Cloud 3.0 with an Economic Driver Award as well as recognized for the innovative solutions it provides to support organizations within the regenerative medicine space to improve quality and patient outcomes through integrated and flexible technology.

Title21 Health Solutions Economic Driver AwardBeyond the Cloud, the annual economic driver awards luncheon hosted by the Pleasanton Chamber of Commerce, included a panel of Pleasanton executives who discussed “what’s next” in technology, business and the economy. Title21 Health Solutions’ CEO, Lynn Fischer, served on the panel with fellow Pleasanton leaders and executives such as Raj Sabhlok, President of Zoho, E. James Macias, President & CEO of Fulcrum Bio Energy, BJ Hardman, Chairman and CEO of Sanarus Technologies, and Tim Cabral, CFO of Veeva Systems. The panel was moderated by Joseph Christiano, Chairman of the Board of the Bank of San Francisco and retired President/CEO of the Kelly-Moore Paint Company.

During the panel Q&A session, Mr. Christiano noted that Title21 has expanded “far beyond just quality management” and asked Ms. Fischer to expand on why and how Title21 Health Solutions has moved into the regenerative medicine space. Ms. Fischer explained that some of the fundamental elements that are core to all of Title21 Health Solutions’ technology, such as one integrated platform as well as a front-end configurable interface, have allowed the flexibility to automate beyond just quality processes. Lynn explained, “It became very clear to uPleasanton Beyond the Clouds that we had something that could be used in an impactful way beyond quality management. We partner with leaders in the regenerative medicine industry to completely automate everything they do. When they process stem cells to infuse in a patient, it is our system – one system – that handles all of the calculations and data validation. It is very complex yet very easy to use on the front-end for those medical technologists and medical directors who need to engage in the software.”


Photographs courtesy of Pam Ellis Photography

No video selected

Select a video type in the sidebar.